AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
30.94
-0.40 (-1.28%)
At close: Oct 3, 2025, 4:00 PM EDT
30.94
0.00 (0.00%)
After-hours: Oct 3, 2025, 4:20 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $866.23 million as of October 3, 2025. Its market cap has decreased by -15.84% in one year.
Market Cap
866.23M
Enterprise Value
947.25M
1-Year Change
-15.84%
Ranking
Category
Stock Price
$30.94
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $866.23M, an increase of 180.60%. That is a compound annual growth rate of 12.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 877.40M | 117.77% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.01B |
| Johnson & Johnson | 447.90B |
| AbbVie | 417.90B |
| UnitedHealth Group | 320.35B |
| AstraZeneca | 259.06B |
| Novo Nordisk | 258.32B |
| Novartis AG | 251.99B |
| Abbott Laboratories | 231.46B |